Search Results

240 results for lsi

3 Highly Rated Biotech Stocks for Your July Buy List

Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street.

The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains

Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector.

The 3 Smartest Healthcare Stocks to Buy With $1K Right Now

The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

We have the biggest pre-market stock movers that investors are going to want to start the trading week with on Monday morning!

The 7 Best Under $10 Stocks to Buy in July 2024

We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into…

Presidential Debate: Painful, Predictable… Perilous

Today, I’m sharing a guest essay from The Freeport Society’s Charles Sizemore that explains how the economic policies proposed by both candidates hurt the average…

3 Psychedelic Stocks to Buy on the Dip: Summer 2024

These are three of the best psychedelic stocks to buy on the dip for potentially lucrative future growth and returns.

AMZN Stock Outlook: Amazon’s Next Growth Wave Could Make Early Investors Rich

After effectively eliminating a threat from low-cost Chinese e-commerce websites and Amazon stock remains attractive.

The 3 Smartest Biotech Stocks to Buy With $5K Right Now

With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. 

3 Under-the-Radar Biotech Stocks With Blockbuster Potential

Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three.

You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.

Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.

7 A-Rated Stocks for Your June Buy List

While there’s no bad time to buy A-rated stocks, these equities represent companies that are must-own picks for June 2024.

3 Promising Stocks That Can Turn $10K Into $1 Million

$10,000 dollars invested in these high-growth stocks can legitimately grow into one million with shorter timelines than expected overall.

3 Valuable Stocks That Are Worth the Expensive Price Tag

Putting your hard-earned money into the stock market? Here are expensive stocks worth buying for the long-term.

3 Blue-Chip Stocks to Buy on the Dip: June 2024

These top blue-chip stocks to buy on the dipare proven winners offering solid long-term growth, reliable dividends and excellent value.

Big Gains…Even When You’re Wrong

The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition

The next trillion dollar stocks have emerged in a few key areas that investors should understand in greater detail in order to profit.

3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt

With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk.  

Sound Investments: 3 Stocks to Buy for a Good Night’s Rest

The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments.

Inflation Comes in as Expected

3 Biotech Stocks to Buy Now: June 2024

These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,

3 Undervalued Renewable Energy Stocks to Buy for 100% Returns in 12 Months

These are the undervalued renewable energy stocks to buy as they represent companies with robust order backlogs.

Wedbush Just Raised Its Price Target on Rivian (RIVN) Stock

Volkswagen is about to invest $5 billion in Rivian. Now Wall Street analysts are pounding the table on RIVN stock.

NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug

Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them.

3 – 10 of 240 results